ETS-3100

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameETS-3100
Drug Alias NameTNF-alpha inhibitor (e-Therapeutics)ETS-3100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesE-Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesE-Therapeutics Plc
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A